Adaptive Biotechnologies Corp (ADPT)
NASDAQ:ADPT
Holding ADPT?
Track your performance easily

Adaptive Biotechnologies (ADPT) Financial Statements

854 Followers

Adaptive Biotechnologies Financial Overview

Adaptive Biotechnologies's market cap is currently ―. The company's EPS TTM is $-1.466; its P/E ratio is -3.81; Adaptive Biotechnologies is scheduled to report earnings on November 7, 2024, and the estimated EPS forecast is $-0.29. See an overview of income statement, balance sheet, and cash flow financials.
Jun 24Mar 24Dec 23Sep 23Jun 23
Income Statement-
Total Revenue$ 43.19M$ 41.87M$ 45.78M$ 37.92M$ 48.93M
Gross Profit$ 23.87M$ 23.82M$ 26.17M$ 18.57M$ 31.02M
EBIT$ -43.55M$ -44.54M$ -15.60M$ -46.67M$ -44.21M
EBITDA$ -35.91M$ -41.97M$ -13.20M$ -43.61M$ -40.47M
Net Income Common Stockholders$ -46.22M$ -47.51M$ -69.44M$ -50.30M$ -47.81M
Balance Sheet-
Cash, Cash Equivalents and Short-Term Investments$ 291.88M$ 308.87M$ 346.40M$ 371.13M$ 417.23M
Total Assets$ 584.87M$ 620.32M$ 661.13M$ 717.68M$ 764.52M
Total Debt$ 226.26M$ 228.04M$ 229.43M$ 231.23M$ 103.52M
Net Debt$ -65.62M$ -80.83M$ -116.97M$ -139.90M$ -313.71M
Total Liabilities$ 343.44M$ 345.56M$ 352.86M$ 356.05M$ 368.57M
Stockholders Equity$ 241.60M$ 274.91M$ 308.40M$ 361.73M$ 396.04M
Cash Flow-
Free Cash Flow$ -19.03M$ -39.86M$ -28.23M$ -49.46M$ -27.25M
Operating Cash Flow$ -17.30M$ -38.35M$ -26.93M$ -46.68M$ -23.56M
Investing Cash Flow$ 5.88M$ 44.51M$ 3.21M$ 26.14M$ 37.32M
Financing Cash Flow$ 30.00K$ 44.00K$ 87.00K$ 17.00K$ 1.47M
Currency in USD

Adaptive Biotechnologies Earnings and Revenue History

Adaptive Biotechnologies Debt to Assets

Adaptive Biotechnologies Cash Flow

Adaptive Biotechnologies Forecast EPS vs Actual EPS

What am I Missing?
Make informed decisions based on Top Analysts' activity
Know what industry insiders are buying
Get actionable alerts from top Wall Street Analysts
Find out before anyone else which stock is going to shoot up
Get powerful stock screeners & detailed portfolio analysis